<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;ff=20231130031104&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;ff=20231130031104&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Thu, 30 Nov 2023 08:11:05 +0000</lastbuilddate>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Reply: Causal Pathway of Alcohol Intake: Stress-Related Neuronal Activity and Cardiovascular Risk</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030356/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):e227-e228. doi: 10.1016/j.jacc.2023.09.825.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030356/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030356</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.825>10.1016/j.jacc.2023.09.825</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030356</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Kenechukwu Mezue</dc:creator>
<dc:creator>Shady Abohashem</dc:creator>
<dc:creator>Michael T Osborne</dc:creator>
<dc:creator>Ahmed Tawakol</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Causal Pathway of Alcohol Intake: Stress-Related Neuronal Activity and Cardiovascular Risk</dc:title>
<dc:identifier>pmid:38030356</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.825</dc:identifier>
</item>
<item>
<title>Causal Pathway of Alcohol Intake: Stress-Related Neuronal Activity and Cardiovascular Risk</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030355/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):e225. doi: 10.1016/j.jacc.2023.06.055.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030355/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030355</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.06.055>10.1016/j.jacc.2023.06.055</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030355</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Gopisankar Mohanannair Geethadevi</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Causal Pathway of Alcohol Intake: Stress-Related Neuronal Activity and Cardiovascular Risk</dc:title>
<dc:identifier>pmid:38030355</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.06.055</dc:identifier>
</item>
<item>
<title>Reporting Extended Follow-Up in Cardiovascular Clinical Trials</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030354/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2246-2250. doi: 10.1016/j.jacc.2023.09.827.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030354/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030354</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.827>10.1016/j.jacc.2023.09.827</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030354</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Mario Gaudino</dc:creator>
<dc:creator>Stuart Pocock</dc:creator>
<dc:creator>Frank Rockhold</dc:creator>
<dc:creator>Deepak L Bhatt</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reporting Extended Follow-Up in Cardiovascular Clinical Trials</dc:title>
<dc:identifier>pmid:38030354</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.827</dc:identifier>
</item>
<item>
<title>Neuroimaging and Neurodevelopmental Outcomes Among Individuals With Complex Congenital Heart Disease: JACC State-of-the-Art Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030353/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>Although neuroimaging advances have deepened our understanding of brain health in individuals with congenital heart disease (CHD), it is less clear how neuroimaging findings relate to neurodevelopmental and mental health outcomes across the lifespan. We systematically synthesized and critically evaluated evidence on associations between neuroimaging and neurodevelopmental, neurocognitive, psychiatric, or behavioral outcomes among individuals with transposition of great arteries or...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2225-2245. doi: 10.1016/j.jacc.2023.09.824.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Although neuroimaging advances have deepened our understanding of brain health in individuals with congenital heart disease (CHD), it is less clear how neuroimaging findings relate to neurodevelopmental and mental health outcomes across the lifespan. We systematically synthesized and critically evaluated evidence on associations between neuroimaging and neurodevelopmental, neurocognitive, psychiatric, or behavioral outcomes among individuals with transposition of great arteries or single-ventricle CHD (Protocol CRD42021229617). Six databases were searched and 45 papers from 25 unique studies were identified. Structural brain injury was generally linked to poorer neurodevelopment in infancy. Brain volumes and microstructural and functional brain changes appear linked to neurocognitive outcomes, including deficits in attention, learning, memory, and executive function in children and adolescents. Fetal neuroimaging studies were limited. Four papers investigated psychiatric outcomes; none found associations with neuroimaging. Multicenter, longitudinal studies incorporating functional neuroimaging and mental health outcomes are much-needed to inform early neuroprotective and therapeutic strategies in CHD.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030353/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030353</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.824>10.1016/j.jacc.2023.09.824</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030353</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Katelyn Phillips</dc:creator>
<dc:creator>Bridget Callaghan</dc:creator>
<dc:creator>Vidya Rajagopalan</dc:creator>
<dc:creator>Farah Akram</dc:creator>
<dc:creator>Jane W Newburger</dc:creator>
<dc:creator>Nadine A Kasparian</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Neuroimaging and Neurodevelopmental Outcomes Among Individuals With Complex Congenital Heart Disease: JACC State-of-the-Art Review</dc:title>
<dc:identifier>pmid:38030353</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.824</dc:identifier>
</item>
<item>
<title>A Responsibility to Perpetually Seek Improved Risk Stratification Models: Achieving Data Nirvana</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030352/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2222-2224. doi: 10.1016/j.jacc.2023.10.004.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030352/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030352</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.004>10.1016/j.jacc.2023.10.004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030352</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>S Adil Husain</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>A Responsibility to Perpetually Seek Improved Risk Stratification Models: Achieving Data Nirvana</dc:title>
<dc:identifier>pmid:38030352</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.004</dc:identifier>
</item>
<item>
<title>Adjusting for Congenital Heart Surgery Risk Using Administrative Data</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030351/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: We created and validated a risk-adjustment model for CHS that accounts for patient and procedural characteristics associated with in-hospital mortality available in administrative data, including the newly developed RACHS-2. Our risk model will be critical for use in health services research and quality improvement initiatives.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2212-2221. doi: 10.1016/j.jacc.2023.09.826.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Congenital heart surgery (CHS) encompasses a heterogeneous population of patients and surgeries. Risk standardization models that adjust for patient and procedural characteristics can allow for collective study of these disparate patients and procedures.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: We sought to develop a risk-adjustment model for CHS using the newly developed Risk Stratification for Congenital Heart Surgery for ICD-10 Administrative Data (RACHS-2) methodology.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Within the Kids' Inpatient Database 2019, we identified all CHSs that could be assigned a RACHS-2 score. Hierarchical logistic regression (clustered on hospital) was used to identify patient and procedural characteristics associated with in-hospital mortality. Model validation was performed using data from 24 State Inpatient Databases during 2017.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 5,902,538 total weighted hospital discharges in the Kids' Inpatient Database 2019, 22,310 pediatric cardiac surgeries were identified and assigned a RACHS-2 score. In-hospital mortality occurred in 543 (2.4%) of cases. Using only RACHS-2, the mortality mode had a C-statistic of 0.81 that improved to 0.83 with the addition of age. A final multivariable model inclusive of RACHS-2, age, payer, and presence of a complex chronic condition outside of congenital heart disease further improved model discrimination to 0.87 (P &lt; 0.001). Discrimination in the validation cohort was also very good with a C-statistic of 0.83.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We created and validated a risk-adjustment model for CHS that accounts for patient and procedural characteristics associated with in-hospital mortality available in administrative data, including the newly developed RACHS-2. Our risk model will be critical for use in health services research and quality improvement initiatives.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030351/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030351</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.826>10.1016/j.jacc.2023.09.826</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030351</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Natalie Jayaram</dc:creator>
<dc:creator>Philip Allen</dc:creator>
<dc:creator>Matthew Hall</dc:creator>
<dc:creator>Tara Karamlou</dc:creator>
<dc:creator>Joyce Woo</dc:creator>
<dc:creator>Sarah Crook</dc:creator>
<dc:creator>Brett R Anderson</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Adjusting for Congenital Heart Surgery Risk Using Administrative Data</dc:title>
<dc:identifier>pmid:38030351</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.826</dc:identifier>
</item>
<item>
<title>Systemic Atrioventricular Valve Regurgitation in Corrected Transposition of the Great Arteries: Where Are We?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030350/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2209-2211. doi: 10.1016/j.jacc.2023.10.022.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030350/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030350</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.022>10.1016/j.jacc.2023.10.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030350</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Sitaram M Emani</dc:creator>
<dc:creator>Pedro J Del Nido</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Systemic Atrioventricular Valve Regurgitation in Corrected Transposition of the Great Arteries: Where Are We?</dc:title>
<dc:identifier>pmid:38030350</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.022</dc:identifier>
</item>
<item>
<title>Systemic Atrioventricular Valve Surgery in Patients With Congenitally Corrected Transposition of the Great Vessels</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030349/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: SAVV surgery remains a valuable option for the treatment of patients with ccTGA, with low early mortality and satisfactory long-term outcomes, particularly in those with SVEF ≥40%. Timely referral and accurate patient selection are the keys to better long-term outcomes.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2197-2208. doi: 10.1016/j.jacc.2023.09.822.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Limited data exist regarding the long-term outcomes of systemic atrioventricular valve (SAVV) intervention (morphologic tricuspid valve) in congenitally corrected transposition (ccTGA).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The goal of this study was to evaluate the mid- and long-term outcomes of SAVV surgery in ccTGA.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We performed a retrospective review of 108 ccTGA patients undergoing SAVV surgery from 1979 to 2022. The primary outcome was a composite endpoint of mortality, cardiac transplantation, or ventricular assist device implantation. The secondary outcome was long-term systemic right ventricular ejection fraction (SVEF). Cox proportional hazard and linear regression models were used to analyze survival and late SVEF data.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The median age at surgery was 39.5 years (Q1-Q3: 28.8-51.0 years), and the median preoperative SVEF was 39% (Q1-Q3: 33.2%-45.0%). Intrinsic valve abnormality was the most common mechanism of SAVV regurgitation (76.9%). There was 1 early postoperative mortality (0.9%). Postoperative complete heart block occurred in 20 patients (18.5%). The actuarial 5-, 10-, and 20-year freedom from death or transplantation was 92.4%, 79.1%, and 62.9%. The 10- and 20-year freedom from valve reoperation was 100% and 93% for mechanical prosthesis compared with 56.6% and 15.7% for bioprosthesis (P &lt; 0.0001). Predictors of postoperative mortality were age at operation (P = 0.01) and preoperative SVEF (P = 0.04). Preoperative SVEF (P &lt; 0.001), complex ccTGA (P = 0.02), severe SAVV regurgitation (P = 0.04), and preoperative creatinine (P = 0.003) were predictors of late postoperative SVEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: SAVV surgery remains a valuable option for the treatment of patients with ccTGA, with low early mortality and satisfactory long-term outcomes, particularly in those with SVEF ≥40%. Timely referral and accurate patient selection are the keys to better long-term outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030349/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030349</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.822>10.1016/j.jacc.2023.09.822</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030349</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Ahmed A Abdelrehim</dc:creator>
<dc:creator>Elizabeth H Stephens</dc:creator>
<dc:creator>William R Miranda</dc:creator>
<dc:creator>Austin L Todd</dc:creator>
<dc:creator>Heidi M Connolly</dc:creator>
<dc:creator>Alexander C Egbe</dc:creator>
<dc:creator>Luke J Burchill</dc:creator>
<dc:creator>Elena A Ashikhmina</dc:creator>
<dc:creator>Joseph A Dearani</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Systemic Atrioventricular Valve Surgery in Patients With Congenitally Corrected Transposition of the Great Vessels</dc:title>
<dc:identifier>pmid:38030349</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.822</dc:identifier>
</item>
<item>
<title>Age-Related Changes of Pulmonary Artery Systolic Pressure: Prevention Is Key</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030348/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2193-2196. doi: 10.1016/j.jacc.2023.10.006.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030348/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030348</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.006>10.1016/j.jacc.2023.10.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030348</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Bernhard Haring</dc:creator>
<dc:creator>Philipp Markwirth</dc:creator>
<dc:creator>Michael Böhm</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Age-Related Changes of Pulmonary Artery Systolic Pressure: Prevention Is Key</dc:title>
<dc:identifier>pmid:38030348</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.006</dc:identifier>
</item>
<item>
<title>Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030347/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Pulmonary pressure increased over 6.5 years in late life, was associated with concomitant increases in LV filling pressure, and predicted the development of dyspnea. Interventions targeting LV diastolic function may be effective at mitigating age-related increases in PASP.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2179-2192. doi: 10.1016/j.jacc.2023.09.821.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Although the prognostic implications of higher pulmonary artery systolic pressure (PASP) are well established, few data exist regarding longitudinal change in pulmonary pressure in late life.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The aim of this study was to quantify changes in PASP over 6 years and determine the relative contributions of cardiac and pulmonary dysfunction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Among 1,420 participants in the ARIC (Atherosclerosis Risk in Communities) study with echocardiographic measures of PASP at both the fifth (2011-2013) and seventh (2018-2019) visits, longitudinal changes in PASP over about 6.5 years were quantified. Multivariable regression was used to determine the extent to which cardiac and pulmonary dysfunction were associated with changes in PASP and to define the relationship of changes in PASP with dyspnea development.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The mean age was 75 ± 5 years at visit 5 and 81 ± 5 years at visit 7, 24% of subjects were Black adults, and 68% were women. Over the 6.5 years, PASP increased by 5 ± 8 mm Hg, from 28 ± 5 to 33 ± 8 mm Hg. PASP increased more in older participants. Predictors of greater increases in PASP included worse left ventricular (LV) systolic and diastolic function, pulmonary function, and renal function. Increases in PASP were associated with concomitant increases in measures of LV filling pressure, including E/e' ratio and left atrial volume index. Each 5 mm Hg increase was associated with 16% higher odds of developing dyspnea (OR: 1.16; 95% CI: 1.07-1.27; P &lt; 0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Pulmonary pressure increased over 6.5 years in late life, was associated with concomitant increases in LV filling pressure, and predicted the development of dyspnea. Interventions targeting LV diastolic function may be effective at mitigating age-related increases in PASP.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030347/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030347</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.09.821>10.1016/j.jacc.2023.09.821</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030347</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Rani Zierath</dc:creator>
<dc:creator>Brian Claggett</dc:creator>
<dc:creator>Victoria Arthur</dc:creator>
<dc:creator>Yimin Yang</dc:creator>
<dc:creator>Hicham Skali</dc:creator>
<dc:creator>Kunihiro Matsushita</dc:creator>
<dc:creator>Dalane Kitzman</dc:creator>
<dc:creator>Suma Konety</dc:creator>
<dc:creator>Thomas Mosley</dc:creator>
<dc:creator>Amil M Shah</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) Study</dc:title>
<dc:identifier>pmid:38030347</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.09.821</dc:identifier>
</item>
<item>
<title>Lesion Selection and Optimizing PCI: Intravascular Hemodynamics, Imaging, or Both?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38030346/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Dec 5;82(23):2177-2178. doi: 10.1016/j.jacc.2023.10.018.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38030346/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38030346</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.018>10.1016/j.jacc.2023.10.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38030346</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Cindy L Grines</dc:creator>
<dc:creator>Allison DuPont</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Lesion Selection and Optimizing PCI: Intravascular Hemodynamics, Imaging, or Both?</dc:title>
<dc:identifier>pmid:38030346</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.018</dc:identifier>
</item>
<item>
<title>Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38029747/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>Mycobacterium tuberculosis (Mtb) causes 1.6 million deaths annually. Active tuberculosis correlates with a neutrophil-driven type I interferon (IFN) signature, but the cellular mechanisms underlying tuberculosis pathogenesis remain poorly understood. We found that interstitial macrophages (IMs) and plasmacytoid dendritic cells (pDCs) are dominant producers of type I IFN during Mtb infection in mice and non-human primates, and pDCs localize near human Mtb granulomas. Depletion of pDCs reduces Mtb...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Nov 18:S0092-8674(23)01217-5. doi: 10.1016/j.cell.2023.11.002. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Mycobacterium tuberculosis (Mtb) causes 1.6 million deaths annually. Active tuberculosis correlates with a neutrophil-driven type I interferon (IFN) signature, but the cellular mechanisms underlying tuberculosis pathogenesis remain poorly understood. We found that interstitial macrophages (IMs) and plasmacytoid dendritic cells (pDCs) are dominant producers of type I IFN during Mtb infection in mice and non-human primates, and pDCs localize near human Mtb granulomas. Depletion of pDCs reduces Mtb burdens, implicating pDCs in tuberculosis pathogenesis. During IFN-driven disease, we observe abundant DNA-containing neutrophil extracellular traps (NETs) described to activate pDCs. Cell-type-specific disruption of the type I IFN receptor suggests that IFNs act on IMs to inhibit Mtb control. Single-cell RNA sequencing (scRNA-seq) indicates that type I IFN-responsive cells are defective in their response to IFNγ, a cytokine critical for Mtb control. We propose that pDC-derived type I IFNs act on IMs to permit bacterial replication, driving further neutrophil recruitment and active tuberculosis disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38029747/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38029747</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.002>10.1016/j.cell.2023.11.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38029747</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Dmitri I Kotov</dc:creator>
<dc:creator>Ophelia V Lee</dc:creator>
<dc:creator>Stefan A Fattinger</dc:creator>
<dc:creator>Charlotte A Langner</dc:creator>
<dc:creator>Jaresley V Guillen</dc:creator>
<dc:creator>Joshua M Peters</dc:creator>
<dc:creator>Andres Moon</dc:creator>
<dc:creator>Eileen M Burd</dc:creator>
<dc:creator>Kristen C Witt</dc:creator>
<dc:creator>Daniel B Stetson</dc:creator>
<dc:creator>David L Jaye</dc:creator>
<dc:creator>Bryan D Bryson</dc:creator>
<dc:creator>Russell E Vance</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis</dc:title>
<dc:identifier>pmid:38029747</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.002</dc:identifier>
</item>
<item>
<title>Temporally multiplexed imaging of dynamic signaling networks in living cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38029746/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>Molecular signals interact in networks to mediate biological processes. To analyze these networks, it would be useful to image many signals at once, in the same living cell, using standard microscopes and genetically encoded fluorescent reporters. Here, we report temporally multiplexed imaging (TMI), which uses genetically encoded fluorescent proteins with different clocklike properties-such as reversibly photoswitchable fluorescent proteins with different switching kinetics-to represent...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Nov 21:S0092-8674(23)01227-8. doi: 10.1016/j.cell.2023.11.010. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Molecular signals interact in networks to mediate biological processes. To analyze these networks, it would be useful to image many signals at once, in the same living cell, using standard microscopes and genetically encoded fluorescent reporters. Here, we report temporally multiplexed imaging (TMI), which uses genetically encoded fluorescent proteins with different clocklike properties-such as reversibly photoswitchable fluorescent proteins with different switching kinetics-to represent different cellular signals. We linearly decompose a brief (few-second-long) trace of the fluorescence fluctuations, at each point in a cell, into a weighted sum of the traces exhibited by each fluorophore expressed in the cell. The weights then represent the signal amplitudes. We use TMI to analyze relationships between different kinase activities in individual cells, as well as between different cell-cycle signals, pointing toward broad utility throughout biology in the analysis of signal transduction cascades in living systems.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38029746/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38029746</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.010>10.1016/j.cell.2023.11.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38029746</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Yong Qian</dc:creator>
<dc:creator>Orhan T Celiker</dc:creator>
<dc:creator>Zeguan Wang</dc:creator>
<dc:creator>Burcu Guner-Ataman</dc:creator>
<dc:creator>Edward S Boyden</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Temporally multiplexed imaging of dynamic signaling networks in living cells</dc:title>
<dc:identifier>pmid:38029746</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.010</dc:identifier>
</item>
<item>
<title>Multi-chamber cardioids unravel human heart development and cardiac defects</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38029745/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>The number one cause of human fetal death are defects in heart development. Because the human embryonic heart is inaccessible and the impacts of mutations, drugs, and environmental factors on the specialized functions of different heart compartments are not captured by in vitro models, determining the underlying causes is difficult. Here, we established a human cardioid platform that recapitulates the development of all major embryonic heart compartments, including right and left ventricles,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Nov 16:S0092-8674(23)01181-9. doi: 10.1016/j.cell.2023.10.030. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The number one cause of human fetal death are defects in heart development. Because the human embryonic heart is inaccessible and the impacts of mutations, drugs, and environmental factors on the specialized functions of different heart compartments are not captured by in vitro models, determining the underlying causes is difficult. Here, we established a human cardioid platform that recapitulates the development of all major embryonic heart compartments, including right and left ventricles, atria, outflow tract, and atrioventricular canal. By leveraging 2D and 3D differentiation, we efficiently generated progenitor subsets with distinct first, anterior, and posterior second heart field identities. This advance enabled the reproducible generation of cardioids with compartment-specific in vivo-like gene expression profiles, morphologies, and functions. We used this platform to unravel the ontogeny of signal and contraction propagation between interacting heart chambers and dissect how mutations, teratogens, and drugs cause compartment-specific defects in the developing human heart.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38029745/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38029745</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.10.030>10.1016/j.cell.2023.10.030</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38029745</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Clara Schmidt</dc:creator>
<dc:creator>Alison Deyett</dc:creator>
<dc:creator>Tobias Ilmer</dc:creator>
<dc:creator>Simon Haendeler</dc:creator>
<dc:creator>Aranxa Torres Caballero</dc:creator>
<dc:creator>Maria Novatchkova</dc:creator>
<dc:creator>Michael A Netzer</dc:creator>
<dc:creator>Lavinia Ceci Ginistrelli</dc:creator>
<dc:creator>Estela Mancheno Juncosa</dc:creator>
<dc:creator>Tanishta Bhattacharya</dc:creator>
<dc:creator>Amra Mujadzic</dc:creator>
<dc:creator>Lokesh Pimpale</dc:creator>
<dc:creator>Stefan M Jahnel</dc:creator>
<dc:creator>Martina Cirigliano</dc:creator>
<dc:creator>Daniel Reumann</dc:creator>
<dc:creator>Katherina Tavernini</dc:creator>
<dc:creator>Nora Papai</dc:creator>
<dc:creator>Steffen Hering</dc:creator>
<dc:creator>Pablo Hofbauer</dc:creator>
<dc:creator>Sasha Mendjan</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Multi-chamber cardioids unravel human heart development and cardiac defects</dc:title>
<dc:identifier>pmid:38029745</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.10.030</dc:identifier>
</item>
<item>
<title>Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38019674/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093/eurheartj/ehad803. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38019674/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38019674</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad803>10.1093/eurheartj/ehad803</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38019674</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Massimo Volpe</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients</dc:title>
<dc:identifier>pmid:38019674</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad803</dc:identifier>
</item>
<item>
<title>A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38019673/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093/eurheartj/ehad802. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38019673/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38019673</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad802>10.1093/eurheartj/ehad802</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38019673</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Zhi-Nan Lu</dc:creator>
<dc:creator>Yizhen Yang</dc:creator>
<dc:creator>Guangyuan Song</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails</dc:title>
<dc:identifier>pmid:38019673</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad802</dc:identifier>
</item>
<item>
<title>Martha Gulati: all-round champion of women's heart health</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38019668/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 29:ehad779. doi: 10.1093/eurheartj/ehad779. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38019668/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38019668</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad779>10.1093/eurheartj/ehad779</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38019668</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Martha Gulati: all-round champion of women's heart health</dc:title>
<dc:identifier>pmid:38019668</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad779</dc:identifier>
</item>
<item>
<title>Can Noncalcified Plaques Contribute to Future Coronary Events?-Reply</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38019524/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Nov 29. doi: 10.1001/jamacardio.2023.4393. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38019524/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38019524</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4393>10.1001/jamacardio.2023.4393</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38019524</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Alastair J Moss</dc:creator>
<dc:creator>Michelle C Williams</dc:creator>
<dc:creator>David E Newby</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Can Noncalcified Plaques Contribute to Future Coronary Events?-Reply</dc:title>
<dc:identifier>pmid:38019524</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4393</dc:identifier>
</item>
<item>
<title>Pulsed Field Ablation-Will Coronary Spasm Lead to Iconoclasm?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38019506/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Nov 29. doi: 10.1001/jamacardio.2023.4441. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38019506/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38019506</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4441>10.1001/jamacardio.2023.4441</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38019506</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Bradley P Knight</dc:creator>
<dc:creator>Anna Pfenniger</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Pulsed Field Ablation-Will Coronary Spasm Lead to Iconoclasm?</dc:title>
<dc:identifier>pmid:38019506</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4441</dc:identifier>
</item>
<item>
<title>Coronary Artery Spasm During Pulsed Field vs Radiofrequency Catheter Ablation of the Mitral Isthmus</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38019505/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSION AND RELEVANCE: When creating a mitral isthmus ablation line during catheter ablation of atrial fibrillation, adjacent left circumflex arterial vasospasm frequently occurred with PFA and not RFA but was typically subclinical.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Nov 29. doi: 10.1001/jamacardio.2023.4405. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: In treating atrial fibrillation, pulsed field ablation (PFA) is a novel energy modality with comparable efficacy to conventional thermal ablation, such as radiofrequency ablation (RFA), but with the benefit of some preferentiality to myocardial tissue ablation. Studies have demonstrated important safety advantages, including the absence of esophageal injury or pulmonary vein stenosis and only rare phrenic nerve injury. However, there is emerging evidence of coronary artery vasospasm provoked by PFA.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To compare the incidence and severity of left circumflex arterial vasospasm between PFA and RFA during adjacent ablation along the mitral isthmus.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study enrolled consecutive adult patients receiving first-ever PFA or RFA of the mitral isthmus during catheter ablation of atrial fibrillation in 2022 with acute follow-up at a single referral European center.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURE: A posterolateral mitral isthmus line was created using either a multielectrode pentaspline PFA catheter (endocardial ablation) or a saline-irrigated RFA catheter. Simultaneous diagnostic coronary angiography was performed before, during, and after catheter ablation. Nitroglycerin was planned for spasm persisting beyond 20 minutes or for significant electrocardiographic changes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The frequency and severity of left circumflex arterial vasospasm was assessed and monitored, as were time to remission and any need for nitroglycerin administration.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 26 included patients, 19 (73%) were male, and the mean (SD) age was 65.5 (9.3) years. Patients underwent either PFA (n = 17) or RFA (n = 9) along the mitral isthmus. Coronary spasm was observed in 7 of 17 patients (41.2%) undergoing PFA: in 7 of 9 (77.8%) when the mitral isthmus ablation line was situated superiorly and in 0 of 8 when situated inferiorly. Conversely, coronary spasm did not occur in any of the 9 patients undergoing RFA. Of 5 patients in whom crossover PFA was performed after RFA failed to achieve conduction block, coronary spasm occurred in 3 (60%). Most instances of spasm (9 of 10 [90%]) were subclinical, with 2 (20%) requiring nitroglycerin administration. The median (range) time to resolution of spasm was 5 (5-25) minutes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION AND RELEVANCE: When creating a mitral isthmus ablation line during catheter ablation of atrial fibrillation, adjacent left circumflex arterial vasospasm frequently occurred with PFA and not RFA but was typically subclinical.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38019505/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38019505</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4405>10.1001/jamacardio.2023.4405</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38019505</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Chi Zhang</dc:creator>
<dc:creator>Petr Neuzil</dc:creator>
<dc:creator>Jan Petru</dc:creator>
<dc:creator>Moritoshi Funasako</dc:creator>
<dc:creator>Pavel Hala</dc:creator>
<dc:creator>Karel Kopriva</dc:creator>
<dc:creator>Jacob S Koruth</dc:creator>
<dc:creator>Srinivas R Dukkipati</dc:creator>
<dc:creator>Vivek Y Reddy</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Coronary Artery Spasm During Pulsed Field vs Radiofrequency Catheter Ablation of the Mitral Isthmus</dc:title>
<dc:identifier>pmid:38019505</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4405</dc:identifier>
</item>
<item>
<title>Can Noncalcified Plaques Contribute to Future Coronary Events?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38019491/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231130031104&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Nov 29. doi: 10.1001/jamacardio.2023.4390. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38019491/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231130031104&v=2.17.9.post6+86293ac">38019491</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4390>10.1001/jamacardio.2023.4390</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38019491</guid>
<pubDate>Wed, 29 Nov 2023 06:00:00 -0500</pubDate>
<dc:creator>Muhammed I Erbay</dc:creator>
<dc:creator>Shriraj Susarla</dc:creator>
<dc:creator>Matthew J Budoff</dc:creator>
<dc:date>2023-11-29</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Can Noncalcified Plaques Contribute to Future Coronary Events?</dc:title>
<dc:identifier>pmid:38019491</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4390</dc:identifier>
</item>





























</channel>
</rss>